Tear Film Deficiency (Dry Eye Syndrome)

What is Tear Film Deficiency?

Tear film deficiency, commonly referred to as dry eye syndrome, occurs when the eyes do not produce enough tears, or when the tears evaporate too quickly, to keep the ocular surface properly lubricated. The tear film is a thin, three‑layered coating (lipid, aqueous, and mucin) that coats the cornea and conjunctiva, providing nourishment, protection, and a smooth optical surface. When any component of this film is disrupted, the eye becomes irritated, vision may blur, and the risk of infection or corneal injury rises.

The condition can be chronic or intermittent and ranges from mild discomfort to severe pain and visual impairment. It is one of the most common ocular problems worldwide, affecting an estimated 5–30 % of the adult population, with higher prevalence in older adults and women, especially after menopause ^[1].

Common Causes

Several medical conditions, environmental factors, and lifestyle habits can impair tear production or increase tear evaporation. The most frequent causes include:

• Age‑related decline in tear production – Lacrimal gland function naturally wanes with age.
• Hormonal changes – Menopause, pregnancy, and thyroid disorders alter tear composition.
• Autoimmune diseases – Sjögren’s syndrome, rheumatoid arthritis, and lupus attack the glands that make tears.
• Medications – Antihistamines, decongestants, antidepressants, β‑blockers, and isotretinoin can reduce tear output.
• Contact lens wear – Long‑term wear disrupts the lipid layer and induces mechanical irritation.
• Environmental exposure – Low humidity, wind, air‑conditioning, or heating dryers cause rapid tear evaporation.
• Meibomian gland dysfunction (MGD) – Blocked oil‑secreting glands lead to an unstable lipid layer.
• Ocular surgeries – LASIK, cataract extraction, or ptosis repair may temporarily impair corneal sensation and tear reflex.
• Blepharitis – Inflammation of the eyelid margins interferes with tear spreading.
• Systemic diseases – Diabetes, Parkinson’s disease, and chronic kidney disease can affect neural control of tear secretion.

Associated Symptoms

Patients with tear film deficiency often experience a constellation of ocular complaints. Typical symptoms include:

• Burning, stinging, or gritty sensation (“like sand in the eye”).
• Redness of the conjunctiva.
• Blurred vision that improves after blinking.
• Excessive tearing (reflex tearing) as the eye tries to compensate.
• Photophobia (light sensitivity).
• Feeling of eye fatigue, especially after screen use.
• Difficulty wearing contact lenses.
• Stringy mucus discharge.

Symptoms often worsen in the evening, in dry climates, or after prolonged visual tasks such as reading or computer work.

When to See a Doctor

While occasional dryness is common, persistent or worsening symptoms merit professional evaluation. Seek eye‑care promptly if you notice:

• Symptoms lasting more than 2–3 weeks despite over‑the‑counter lubricants.
• Severe pain, sudden loss of vision, or a sensation of a foreign body that does not improve with blinking.
• Frequent eye infections (conjunctivitis, blepharitis) or corneal ulcers.
• Persistent redness coupled with discharge.
• Difficulty performing daily activities such as reading, driving, or using a computer.

Early evaluation helps prevent complications such as corneal erosion, scarring, or permanent visual impairment.

Diagnosis

Eye specialists (optometrists or ophthalmologists) use a combination of history taking, examinations, and diagnostic tests to confirm tear film deficiency.

Clinical Assessment

• Patient history – Duration, triggers, medication list, systemic diseases.
• Slit‑lamp examination – Evaluates eyelid margins, meibomian glands, corneal staining, and tear meniscus height.
• Fluorescein or Lissamine Green staining – Highlights areas of epithelial damage on the cornea and conjunctiva.

Objective Tests

• Schirmer test – Measures basal tear production using a filter paper strip placed under the lower eyelid for 5 minutes.
• Tear Break‑Up Time (TBUT) – Assesses tear film stability; a fluorescein dye is applied and the time for the first dry spot is recorded (normal >10 seconds).
• Ocular Surface Disease Index (OSDI) questionnaire – Standardized symptom score.
• Meibography – Infrared imaging of meibomian gland morphology.
• Osmolarity testing – High tear osmolarity (>308 mOsm/L) is a hallmark of dry eye.

These tests help differentiate between aqueous‑deficient dry eye, evaporative dry eye, or a mixed form, guiding targeted therapy ^[2].

Treatment Options

Treatment is individualized based on severity, underlying cause, and patient preferences. A step‑wise approach is recommended, beginning with lifestyle modifications and advancing to prescription therapies if needed.

Home & Lifestyle Measures

• Artificial tears – Preservative‑free drops used 4–6 times daily; gels or ointments for nighttime use.
• Warm compresses and lid hygiene – 5–10 minutes of warm compresses followed by gentle lid scrubs (e.g., diluted baby shampoo) improves meibomian gland function.
• Environmental control – Use humidifiers, avoid direct fans, wear wrap‑around sunglasses outdoors.
• Screen ergonomics – Follow the 20‑20‑20 rule (every 20 min, look at something 20 ft away for 20 seconds) and consider blinking exercises.
• Hydration and diet – Increase water intake; omega‑3 fatty acids (fish oil or flaxseed) have modest benefit.
• Medication review – Discuss with your physician the possibility of substituting tear‑reducing drugs.

Prescription Medications

• Anti‑inflammatory agents
  • Cycloplegic eye drops (e.g., cyclosporine ophthalmic 0.05 % – Restasis) to increase tear production.
  • Lifitegrast (Xiidra) – Targets ocular surface inflammation.
• Punctal plugs – Small silicone or collagen devices inserted into the tear drainage canals to retain tears.
• Topical corticosteroids – Short courses for severe inflammation under close supervision.
• Autologous serum eye drops – For refractory cases; contains growth factors and vitamins similar to natural tears.
• Omega‑3 supplementation – 1000 mg EPA/DHA daily, shown to improve symptoms in some clinical trials.

Procedural Interventions

• Meibomian gland expression – Manual or thermal expression performed in the office.
• Thermal pulsation devices (e.g., LipiFlow) – Apply controlled heat and pressure to unblock glands.
• Laser or intense pulsed light (IPL) therapy – Reduces inflammation and improves gland function.
• Amniotic membrane grafts – For severe corneal epithelial breakdown.

Follow‑up Care

Most patients require periodic reassessment (every 3–6 months) to monitor symptom control, adjust therapy, and screen for complications.

Prevention Tips

While some risk factors (age, genetics) cannot be altered, many everyday habits can reduce the likelihood of developing tear film deficiency or keep it from worsening:

• Maintain a humid indoor environment, especially in winter.
• Take regular breaks during prolonged visual tasks; blink deliberately.
• Protect eyes from wind, dust, and smoke with goggles or protective eyewear.
• Limit exposure to screens that emit blue light; consider screen filters.
• Adopt a balanced diet rich in omega‑3 fatty acids, vitamin A, and antioxidants.
• Avoid smoking and second‑hand smoke.
• Schedule routine eye exams, especially if you have systemic autoimmune disease.
• Ensure proper fit and cleaning of contact lenses; replace them as recommended.

Emergency Warning Signs

---

References:

• 1. American Academy of Ophthalmology. “Dry Eye.” https://www.aao.org/eye-health/diseases/dry-eye-syndrome (accessed May 2026).
• 2. Craig JP, et al. “TFOS DEWS II Report.” Ocular Surface. 2017;15(2):269‑320. PMID: 28464374.
• 3. Mayo Clinic. “Dry eye.” https://www.mayoclinic.org/diseases-conditions/dry-eye/symptoms-causes/syc-20371876 (accessed May 2026).
• 4. National Eye Institute (NEI). “Facts About Dry Eye.” https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/dry-eye (2024).
• 5. WHO. “Vision Impairment and Blindness.” https://www.who.int/teams/health-care-quality-and-safety/vision (2023).